Cite
O1-1-1 Prediction of toxicity in R/R DLBCL treated with Axicabtagene Clioleucel (19-28z CAR T).
MLA
Kotani, Hiroshi, et al. “O1-1-1 Prediction of Toxicity in R/R DLBCL Treated with Axicabtagene Clioleucel (19-28z CAR T).” Annals of Oncology, vol. 30, Oct. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1093/annonc/mdz339.
APA
Kotani, H., Faramand, R., Lee, S. B., Yu, B., Morrissey, D., Locke, F. L., Jain, M. D., Chavez, J. C., Wang, X., Mishra, A., Bachmeier, C. A., Brentjens, R. J., Yoo, S., Park, J. H., & Davila, M. L. (2019). O1-1-1 Prediction of toxicity in R/R DLBCL treated with Axicabtagene Clioleucel (19-28z CAR T). Annals of Oncology, 30, N.PAG. https://doi.org/10.1093/annonc/mdz339
Chicago
Kotani, Hiroshi, Rawan Faramand, Sae Bom Lee, Bin Yu, Dylan Morrissey, Frederick L Locke, Michael D Jain, et al. 2019. “O1-1-1 Prediction of Toxicity in R/R DLBCL Treated with Axicabtagene Clioleucel (19-28z CAR T).” Annals of Oncology 30 (October): N.PAG. doi:10.1093/annonc/mdz339.